S

Sarepta Therapeutics
D

SRPT

37.900
USD
-0.90
(-2.32%)
مفتوح الان
حجم التداول
46,391
الربح لكل سهم
2
العائد الربحي
-
P/E
-14
حجم السوق
3,722,733,972
أصول ذات صلة
AMGN
AMGN
-0.70
(-0.26%)
271.35 USD
BIIB
BIIB
-0.760
(-0.60%)
125.530 USD
BMRN
BMRN
-0.610
(-1.05%)
57.380 USD
GILD
GILD
0.630
(0.59%)
107.350 USD
INCY
INCY
-0.060
(-0.09%)
64.440 USD
I
IONS
-0.385
(-1.16%)
32.880 USD
R
RCKT
-0.40000
(-6.11%)
6.15000 USD
REGN
REGN
-9.06
(-1.52%)
587.59 USD
VRTX
VRTX
1.29
(0.30%)
435.45 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.